1994
DOI: 10.1038/jcbfm.1994.134
|View full text |Cite
|
Sign up to set email alerts
|

3-Acetylpyridine Produces Age-Dependent Excitotoxic Lesions in Rat Striatum

Abstract: Summary: The effects of 3-acetylpyridine (3-AP) were studied in rat striatum. Striatal injections of 3-AP pro duced dose-dependent lesions. The lesion size was signif icantly increased in 4-and 12-month-old rats compared to l-month-old rats. Coinjection of the competitive N-meth yl-D-aspartate (NMDA) antagonist 2-amino-5-phosphonovaleric acid (APV) or systemic administration of the noncompetitive NMDA antagonist MK-801, the competitive NMDA antagonist L Y274614, or the gluta mate release inhibitor lamotrigine … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
7
0

Year Published

1995
1995
2014
2014

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 36 publications
(7 citation statements)
references
References 21 publications
0
7
0
Order By: Relevance
“…Thus, in rat studies, LTG attenuated lesion volume with striatal injections of the excitotoxin 3-acetylpyridine, 90 and hippocampal slice perfusion with 0.1-mM LTG and 1.2-to 1.6-mM FBM (but not placebo) decreased irreversible disappearance of the CA1 electrical responses induced by kainate (but not by NMDA or a-amino-3-hydroxy-5-methylisoxazole-4-propionic acid). 91 LTG pretreatment reduced hippocampal neuronal loss but only tended to protect from seizures in the kainate-induced multifocal status epilepticus rat model of intractable complex partial seizures and neurotoxicity.…”
Section: Putative Neuroprotective Effectsmentioning
confidence: 88%
“…Thus, in rat studies, LTG attenuated lesion volume with striatal injections of the excitotoxin 3-acetylpyridine, 90 and hippocampal slice perfusion with 0.1-mM LTG and 1.2-to 1.6-mM FBM (but not placebo) decreased irreversible disappearance of the CA1 electrical responses induced by kainate (but not by NMDA or a-amino-3-hydroxy-5-methylisoxazole-4-propionic acid). 91 LTG pretreatment reduced hippocampal neuronal loss but only tended to protect from seizures in the kainate-induced multifocal status epilepticus rat model of intractable complex partial seizures and neurotoxicity.…”
Section: Putative Neuroprotective Effectsmentioning
confidence: 88%
“…3-Acetylpyridine is a niacinamide antagonist that impairs energy metabolism due to its substitution for niacinamide in NAD(P) formation and has potent neurotoxic properties in vitro and in vivo (Sethy et al, 1997). 3-Acetylpyridine neurotoxicity also has an NMDA receptor excitotoxic component, and the NMDA antagonist MK-801 can diminish its toxicity (Schulz et al, 1994). The GABA inverse agonist PNU-101017 demonstrated a partial but significant neuroprotective effect 8 h after administration of 3-acetylpyridine in rats (Sethy et al, 1997).…”
Section: Benzodiazepine Receptor and 'Inverse' Agonistsmentioning
confidence: 98%
“…In addition, mitochondrial dysfunction will enhance the production of reactive oxygen species (ROS), which will also contribute to neuronal damage (Murphy et al, 1999). Substantial evidence indicates that mitochondrial toxins induce neuronal damage through an excitotoxic‐mediated mechanism (Storey et al, 1992; Beal et al, 1993; Grenee et al, 1993; Brouillet et al, 1994; Schulz et al, 1994) and potentiate glutamate neurotoxicity both in vivo and in vitro (Novelli et al, 1988; Greene and Greenamyre, 1995; Cebers et al, 1998; Greene et al, 1998; Sánchez‐Carbente and Massieu, 1999). All these studies favor the hypothesis of a close and complex interrelation between mitochondrial energy metabolism and glutamate excitotoxicity (Henneberry, 1989).…”
Section: Introductionmentioning
confidence: 99%